Trinity Biotech plc Gains 34.12%
Wed, Jan 31, 2024 at 07:22 PM
Trinity Biotech plc (TRIB:NASDAQ) shot up at $0.59, a gain of 34.1%. On Wed, Jan 31, 2024, TRIB:NASDAQ touched a New 2-Week High of $0.59. The stock appeared on our News Catalysts scanner on Wed, Jan 31, 2024 at 08:19 AM in the 'BIOTECH' category. From Wed, Jan 17, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
About Trinity Biotech plc (TRIB:NASDAQ)
Trinity Biotech PLC develops, manufactures and markets clinical diagnostic products. Its products are used for detecting autoimmune, sexually transmitted diseases, diabetes and disorders of the liver.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 212.5%
- Infobird Co. Ltd (IFBD:NASDAQ), 115.87%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 101.21%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 56.93%
- Earlyworks Co. Ltd. (ELWS:NASDAQ), 55.29%
- Powell Industries, Inc. (POWL:NASDAQ), 45.28%
- Momentus Inc. (MNTS:NASDAQ), 41.86%
- Electriq Power Holdings Inc. Class A (ELIQ:NYSE), 38.46%
- Trinity Biotech plc (TRIB:NASDAQ), 34.12%
- Nyxoah SA (NYXH:NASDAQ), 32.92%